Tag: Vaccines

Absolute increase in 30-day relapse risk associated with the second or third vaccine dose is small

FDA says findings affirm its decision to approve the booster without human testing based on experience with a similarly tweaked vaccine

Coverage levels for three doses of DTP-containing vaccine, measles-containing vaccine down to lowest levels since 2008

Pooled 30 percent increased risk for thrombocytopenia seen after first dose of ChAdOx1-S versus BNT162b2

Injection-site, musculoskeletal, dermatologic, otolaryngologic symptoms more frequent; general symptoms and fever less frequent with BNT162b2 in children younger than 5 years of age

Seroprotection rate increased from 94.4 percent at eight weeks after second dose to 98.5 percent at week 24

Advantages to inhaled vaccine include the concept of priming the area of the body where the virus often enters

Greatest declines in incidence, hospitalization, death seen for those aged younger than 20 years, at 99, 97, and >99 percent

Vaccination against HPV before sexual debut advised for maximum effectiveness in female individuals

HCP who reported employer vaccination requirements had higher vaccination coverage for flu, COVID-19 primary series, COVID-19 booster